Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as ... - Yahoo Finance

PVCTDelisted Stock  USD 0.11  0.00  0.00%   
Slightly above 56% of Provectus Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading Provectus Biopharmaceuticals otc stock suggests that many investors are alarmed at this time. Provectus Biopharmaceutica's investing sentiment can be driven by a variety of factors including economic data, Provectus Biopharmaceutica's earnings reports, geopolitical events, and overall market trends.
  
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as ... Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Provectus Biopharmaceutica Fundamental Analysis

We analyze Provectus Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Provectus Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Provectus Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Z Score

Z Score Comparative Analysis

Provectus Biopharmaceutica is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Provectus Biopharmaceutica Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Provectus Biopharmaceutica otc stock to make a market-neutral strategy. Peer analysis of Provectus Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Provectus Biopharmaceutica by comparing valuation metrics with similar companies.

Peers

Provectus Biopharmaceutica Related Equities

CYCCCyclacel Pharmaceuticals   24.32   
0%
100.0%
TARAProtara Therapeutics   10.04   
0%
41.0%
IPSCCentury Therapeutics   6.73   
0%
27.0%
ACXPAcurx Pharmaceuticals   5.95   
0%
24.0%
KZRKezar Life   4.41   
0%
18.0%
MLYSMineralys Therapeutics,   4.08   
0%
16.0%
CLDXCelldex Therapeutics   3.96   
0%
16.0%
CRNXCrinetics Pharmaceuticals   3.10   
0%
12.0%
XLOXilio Development   2.80   
0%
11.0%
IKNAIkena Oncology   2.42   
0%
9.0%
SRRKScholar Rock   2.29   
0%
9.0%
KNSAKiniksa Pharmaceuticals   1.86   
0%
7.0%
NKTXNkarta   0.40   
0%
1.0%
AVTEAerovate Therapeutics   0.37   
1.0%
0%
NGENFNervGen Pharma   5.17   
21.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Provectus OTC Stock

If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.